Maria Alma Rodriguez

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

Zheng Zhou, Laurie H. Sehn, Alfred Rademaker et al. · Blood · 2013 · 953 citations

Medicine, Hematology, Oncology +14

High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine

Jorge Romaguera, Luis Fayad, Maria Alma Rodriguez et al. · Journal of Clinical Oncology · 2005 · 559 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma

Lorenzo Cohen, Carla L. Warneke, Rachel T. Fouladi et al. · Cancer · 2004 · 498 citations · Full text

Medicine, Oncology, Cancer Rehabilitation +13

ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.

William S. Velasquez, Peter McLaughlin, Fredrick B. Hagemeister et al. · Journal of Clinical Oncology · 1994 · 430 citations

Medicine, Oncology, Pharmacotherapy +13

Double hit lymphoma: the <scp>MD A</scp> nderson <scp>C</scp> ancer <scp>C</scp> enter clinical experience

Yasuhiro Oki, Mansoor Noorani, Pei Lin et al. · British Journal of Haematology · 2014 · 364 citations

Medicine, Hematology, Oncology +13